Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
B. S. Ravindranath, S. Vishnu Vinayak & Vivek Chandra mohan. (2022) RNR inhibitor binding studies of Chlamydia felis: insights from in silico molecular modeling, docking, and simulation studies. Journal of Biomolecular Structure and Dynamics 40:19, pages 9416-9428.
Read now
Read now
Loretta J Nastoupil, Rajni Sinha & Christopher R Flowers. (2013) The role of chemotherapy in managing chronic lymphocytic leukemia: optimizing combinations with targeted therapy. Expert Review of Anticancer Therapy 13:9, pages 1089-1108.
Read now
Read now
Articles from other publishers (44)
Barbara Kutryb-Zając, Ada Kawecka, Khrystyna Nasadiuk, Alicja Braczko, Klaudia Stawarska, Elisabetta Caiazzo, Patrycja Koszałka & Carla Cicala. (2023) Drugs targeting adenosine signaling pathways: A current view. Biomedicine & Pharmacotherapy 165, pages 115184.
Crossref
Crossref
Norihiro Sakai, Kenya Kamimura & Shuji Terai. (2023) Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs. Pharmaceutics 15:9, pages 2190.
Crossref
Crossref
Alexandre Bazinet, Faezeh Darbaniyan, Tapan M. Kadia, Sangeetha Venugopal, Rashmi Kanagal‐Shamanna, Courtney D. DiNardo, Gautam Borthakur, Elias J. Jabbour, Naval G. Daver, Naveen Pemmaraju, Marina Y. Konopleva, Farhad Ravandi, Koji Sasaki, Kelly S. Chien, Danielle Hammond, Sherry A. Pierce, Hagop M. Kantarjian, Guillermo Garcia‐Manero & Guillermo Montalban‐Bravo. (2022) A retrospective study of cladribine and low‐dose cytarabine–based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia. Cancer 129:4, pages 560-568.
Crossref
Crossref
Surya K. De. 2023. Medicines for Cancer. Medicines for Cancer
7
159
.
Ranjit Singh, Anjleena Malhotra & Ranju Bansal. 2023. Medicinal Chemistry of Chemotherapeutic Agents. Medicinal Chemistry of Chemotherapeutic Agents
499
537
.
Chakrabhavi Dhananjaya Mohan, Shobith Rangappa, S. Chandra Nayak, Ragi Jadimurthy, Lingzhi Wang, Gautam Sethi, Manoj Garg & Kanchugarakoppal S. Rangappa. (2022) Bacteria as a treasure house of secondary metabolites with anticancer potential. Seminars in Cancer Biology 86, pages 998-1013.
Crossref
Crossref
Alberto Monroy-Mora, María de Lourdes Mora-García, Katia Alheli Monroy Mora, Jorge Hernández-Montes, Rosario García-Rocha, Christian Azucena Don-López, Benny Weiss-Steider, Juan José Montesinos-Montesinos & Alberto Monroy-García. (2022) Inhibition of adenosine deaminase activity reverses resistance to the cytotoxic effect of high adenosine levels in cervical cancer cells. Cytokine 158, pages 155977.
Crossref
Crossref
Hongyu Zhang, Ran Liu, Tingting Lou, Pei Zhao & Suying Wang. (2022) Pentostatin Biosynthesis Pathway Elucidation and Its Application. Fermentation 8:9, pages 459.
Crossref
Crossref
Galal H. Elgemeie & Reham A. Mohamed-Ezzat. 2022. New Strategies Targeting Cancer Metabolism. New Strategies Targeting Cancer Metabolism
69
105
.
Julia Frisch, Tin Maršić & Christoph Loderer. (2021) A Novel One-Pot Enzyme Cascade for the Biosynthesis of Cladribine Triphosphate. Biomolecules 11:3, pages 346.
Crossref
Crossref
Kamylla Fernanda Souza de Souza, Luciana Rocha Costa, Edgar J. Paredes-Gamero & Jeandre Augusto dos Santos Jaques. 2021. Sinalização purinérgica: implicações fisiopatológicas. Sinalização purinérgica: implicações fisiopatológicas
190
210
.
Kyrylo Klimenko. (2021) Examining the evidence of non-monotonic dose-response in Androgen Receptor agonism high-throughput screening assay. Toxicology and Applied Pharmacology 410, pages 115338.
Crossref
Crossref
Nathan M. Merrill, Nathalie M. Vandecan, Kathleen C. Day, Phillip L. Palmbos, Mark L. Day, Aaron M. Udager, Sofia D. Merajver & Matthew B. Soellner. (2020) MEK is a promising target in the basal subtype of bladder cancer. Oncotarget 11:44, pages 3921-3932.
Crossref
Crossref
Victoria C. Woolley, Graham R. Teakle, Gillian Prince, Cornelia H. de Moor & David Chandler. (2020) Cordycepin, a metabolite of Cordyceps militaris, reduces immune-related gene expression in insects. Journal of Invertebrate Pathology 177, pages 107480.
Crossref
Crossref
Tamás Biernacki, Dániel Sandi, Krisztina Bencsik & László Vécsei. (2020) Medicinal Chemistry of Multiple Sclerosis: Focus on Cladribine. Mini-Reviews in Medicinal Chemistry 20:4, pages 269-285.
Crossref
Crossref
Ahmet Sureyya Rifaioglu, Esra Nalbat, Volkan Atalay, Maria Jesus Martin, Rengul Cetin-Atalay & Tunca Doğan. (2020) DEEPScreen: high performance drug–target interaction prediction with convolutional neural networks using 2-D structural compound representations. Chemical Science 11:9, pages 2531-2557.
Crossref
Crossref
Clinton B. Mathias & Jeremy P. McAleer. 2020. Pharmacology of Immunotherapeutic Drugs. Pharmacology of Immunotherapeutic Drugs
251
276
.
S. Bagheri, A.A. Saboury & T. Haertlé. (2019) Adenosine deaminase inhibition. International Journal of Biological Macromolecules 141, pages 1246-1257.
Crossref
Crossref
Camici, Garcia-Gil, Pesi, Allegrini & Tozzi. (2019) Purine-Metabolising Enzymes and Apoptosis in Cancer. Cancers 11:9, pages 1354.
Crossref
Crossref
Ayman Qasrawi, Waled Bahaj, Lien Qasrawi, Omar Abughanimeh, John Foxworth & Rakesh Gaur. (2018) Cladribine in the remission induction of adult acute myeloid leukemia: where do we stand?. Annals of Hematology 98:3, pages 561-579.
Crossref
Crossref
Devesh Tewari, Pooja Rawat & Pawan Kumar Singh. (2019) Adverse drug reactions of anticancer drugs derived from natural sources. Food and Chemical Toxicology 123, pages 522-535.
Crossref
Crossref
Ji Won Lee, Youn Mi Choi, Jae Yun Yang, Seung Moon Han, Bong Seog Kim & Seung-Hyun Nam. (2018) Fludarabine and Rituximab in Relapsed or Refractory Hairy Cell Leukmia Variant: A Case Report and Review of Literature. Kosin Medical Journal 33:3, pages 438-445.
Crossref
Crossref
Vern L. Schramm. (2018) Enzymatic Transition States and Drug Design. Chemical Reviews 118:22, pages 11194-11258.
Crossref
Crossref
Gudan Xu, Liyuan Kong, Rong Gong, Liudong Xu, Yaojie Gao, Ming Jiang, You-Sheng Cai, Kui Hong, Youcai Hu, Peng Liu, Zixin Deng, Neil P. J. Price & Wenqing Chen. (2018) Coordinated Biosynthesis of the Purine Nucleoside Antibiotics Aristeromycin and Coformycin in Actinomycetes. Applied and Environmental Microbiology 84:22.
Crossref
Crossref
Nikolaos Tsesmetzis, Cynthia Paulin, Sean Rudd & Nikolas Herold. (2018) Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism. Cancers 10:7, pages 240.
Crossref
Crossref
Tamim Alsuliman, Kaiss Lassoued, Maifa Belghoul, Karima Debbache & Bachra Choufi. (2017) Durable Resolution of Severe Psoriasis in a Patient Treated with Pentostatin for Hairy Cell Leukemia: A Case Report. Dermatology and Therapy 8:1, pages 165-169.
Crossref
Crossref
Nicole S. Klee, Cameron G. McCarthy, Patricia Martinez-Quinones & R. Clinton Webb. (2017) Out of the frying pan and into the fire: damage-associated molecular patterns and cardiovascular toxicity following cancer therapy. Therapeutic Advances in Cardiovascular Disease 11:11, pages 297-317.
Crossref
Crossref
Ludwik Jasinski, Patrycja Chylinska-Wrzos, Marta Lis-Sochocka, Ewelina Wawryk-Gawda & Barbara Jodlowska-Jedrych. (2017) A comparison of caspase 3 expression in the endocrine and exocrine parts of the pancreas after cladribine application according to the "leukemic" schema. Current Issues in Pharmacy and Medical Sciences 30:1, pages 9-15.
Crossref
Crossref
Vipin Mohan Dan & Rahul Sanawar. 2017. Bioresources and Bioprocess in Biotechnology. Bioresources and Bioprocess in Biotechnology
171
184
.
Sara E.F. Kost, Eric D.J. Bouchard, ?lise LaBossi?re, Xibiao Ye, Michelle L. Queau, William S. Liang, Versha Banerji, Spencer B. Gibson, Sachin Katyal & James B. Johnston. (2016) Cross-resistance and synergy with bendamustine in chronic lymphocytic leukemia. Leukemia Research 50, pages 63-71.
Crossref
Crossref
M.A. Garza-Ledezma, C.A. Tellez-Hinojosa, E.E. González-López & D. Gómez-Almaguer. (2016) Hairy cell leukemia, an uncommon B-cell lymphoid neoplasia. Medicina Universitaria 18:70, pages 34-41.
Crossref
Crossref
Luiz F. Ferrari, Oliver Bogen, David B. Reichling & Jon D. Levine. (2015) Accounting for the Delay in the Transition from Acute to Chronic Pain: Axonal and Nuclear Mechanisms. The Journal of Neuroscience 35:2, pages 495-507.
Crossref
Crossref
Daniel H. Fowler & David C. Halverson. 2015. Developments in T Cell Based Cancer Immunotherapies. Developments in T Cell Based Cancer Immunotherapies
281
302
.
Antoni Cortés, Eduard Gracia, Estefania Moreno, Josefa Mallol, Carme Lluís, Enric I. Canela & Vicent Casadó. (2015) Moonlighting Adenosine Deaminase: A Target Protein for Drug Development. Medicinal Research Reviews 35:1, pages 85-125.
Crossref
Crossref
Paola de Andrade Mello, Eduardo Cremonese Filippi-Chiela, Jéssica Nascimento, Aline Beckenkamp, Danielle Bertodo Santana, Franciele Kipper, Emerson André Casali, Alessandra Nejar Bruno, Juliano Domiraci Paccez, Luiz Fernando Zerbini, Marcia Rosângela Wink, Guido Lenz & Andréia Buffon. (2014) Adenosine uptake is the major effector of extracellular ATP toxicity in human cervical cancer cells. Molecular Biology of the Cell 25:19, pages 2905-2918.
Crossref
Crossref
Michael R. Grever, James S. Blachly & Leslie A. Andritsos. (2014) Hairy cell leukemia: Update on molecular profiling and therapeutic advances. Blood Reviews 28:5, pages 197-203.
Crossref
Crossref
Preetesh Jain, Naveen Pemmaraju & Farhad Ravandi. (2014) Update on the Biology and Treatment Options for Hairy Cell Leukemia. Current Treatment Options in Oncology 15:2, pages 187-209.
Crossref
Crossref
Ewelina Wawryk-Gawda, Patrycja Chyli?ska-Wrzos, Marta Lis-Sochocka, Katarzyna Ch?apek, Kamila Bulak, Marian J?drych & Barbara Jod?owska-J?drych. (2013) P53 protein in proliferation, repair and apoptosis of cells. Protoplasma 251:3, pages 525-533.
Crossref
Crossref
V Maevis, U Mey, G Schmidt-Wolf & I G H Schmidt-Wolf. (2014) Hairy cell leukemia: short review, today’s recommendations and outlook. Blood Cancer Journal 4:2, pages e184-e184.
Crossref
Crossref
Ewelina Wawryk-Gawda, Patrycja Chylińska-Wrzos, Marta Lis-Sochocka, Kamila Bulak & Barbara Jodłowska-Jędrych. (2014) Intrinsic Apoptosis Pathway in Fallopian Tube Epithelial Cells Induced by Cladribine. The Scientific World Journal 2014, pages 1-9.
Crossref
Crossref
Marian Jędrych, Ewelina Wawryk-Gawda, Barbara Jodłowska-Jędrych, Patrycja Chylińska-Wrzos & Ludwik Jasiński. (2013) Immunohistochemical evaluation of cell proliferation and apoptosis markers in ovarian surface epithelial cells of cladribine-treated rats. Protoplasma 250:5, pages 1025-1034.
Crossref
Crossref
Krystyna Mitosek-Szewczyk, Jacek Tabarkiewicz, Barbara Wilczynska, Katarzyna Lobejko, Jerzy Berbecki, Marcin Nastaj, Ewa Dworzanska, Beata Kolodziejczyk, Zbigniew Stelmasiak & Jacek Rolinski. (2013) Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis. Journal of the Neurological Sciences 332:1-2, pages 35-40.
Crossref
Crossref
Krzysztof Komodziński, Jolanta Lepczyńska, Piotr Ruszkowski, Jan Milecki & Bohdan Skalski. (2013) Biological evaluation of an imidazole-fused 1,3,5-triazepinone nucleoside and its photochemical generation via a 6-azidopurine modified oligonucleotide. Tetrahedron Letters 54:29, pages 3781-3784.
Crossref
Crossref
Patrycja Chylinska-Wrzos, Ewelina Wawryk-Gawda, Marta Lis-Sochocka, Marian Jedrych, Miroslaw Lancut, Kamila Bulak, Joanna Leszcz-Stankiewicz & Barbara Jodlowska-Jedrych. (2013) The intrinsic or the extrinsic pathways of apoptosis in the epidermis after cladribine application?. Journal of Biomedical Science and Engineering 06:03, pages 265-272.
Crossref
Crossref